Cardio Diagnostics Holdings, Inc. (CDIO)

↓ Download CSV

CIK 0001870144 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Cardio Diagnostics Holdings, Inc. reported revenue of $14.8K, down 57.5% from the prior year. The company ran a net loss, with a net margin of -43832.5%. It held $7.77M in total assets against $793.1K in total liabilities.

Key ratios (FY2025)

-43737.5%
Operating margin
-43832.5%
Net margin
-93.2%
Return on equity
-57.5%
Revenue growth (YoY)
Metric (FY)202520242023202220212020
Revenue$14.8K$34.9K$17.1K$950$901
Operating Income-$6.48M-$8.37M-$7.24M-$4.55M-$620.4K
Net Income-$6.50M-$8.38M-$8.38M-$4.66M-$620.4K
EPS (Diluted)$-3.71$-9.35$-0.66$-1.51$-0.53
Total Assets$7.77M$10.62M$4.46M$6.25M$1.10M
Total Liabilities$793.1K$1.06M$1.50M$1.95M$33.9K
Shareholders' Equity$6.97M$9.56M$2.96M$4.30M$1.07M$60.4K
Cash & Equivalents$0$0$0$0$0
Operating Cash Flow-$5.73M-$4.99M-$5.67M-$5.09M-$585.3K
Capital Expenditures$187.3K$214.8K$575.7K
Shares Outstanding1.83M1.53M20.54M9.51M1.23M